NCT06508450 A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
| NCT ID | NCT06508450 |
| Status | Recruiting |
| Phase | — |
| Sponsor | New York University |
| Condition | Psychosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-12-18 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-12-18 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Researchers aim to test a brief culturally-responsive young adult orientation program for community mental health services. They will conduct a 24-month randomized trial with 80 young adults from racial and ethnic minority groups in a community-based mental health clinic.
Eligibility Criteria
Inclusion Criteria: * Aged 18-34 * From groups other than non-Hispanic White * Enrolled in services at the partnering clinic site Exclusion Criteria: * Cognitive impairments (i.e., young adult cannot understand consent process) * Unable to comprehend and speak English
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06508450 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 34 Years, studying Psychosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06508450 currently recruiting?
Yes, NCT06508450 is actively recruiting participants. Contact the research team at kiara.moore@nyu.edu for enrollment information.
Where is the NCT06508450 trial being conducted?
This trial is being conducted at The Bronx, United States.
Who is sponsoring the NCT06508450 clinical trial?
NCT06508450 is sponsored by New York University. The trial plans to enroll 80 participants.